Drug Database
Back to search

Poland· PL-100426730

Yasmin

A progestogens and estrogens, fixed combinations product containing ethinylestradiolum + drospirenonum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 3 of our 19 countries.

ATC G03AA

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedYasminATCG03AAREGISTER NO.PL-100426730PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ethinylestradiolum + drospirenonumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ethinylestradiolum + drospirenonum is registered in 3 of 19 countries.

Countries holding a registration under ATC G03AA (progestogens and estrogens, fixed combinations), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose
Search ethinylestradiolum + drospirenonum products by name

Ethinylestradiolum + drospirenonum · ATC G03AA

3 / 19 countries

  • Belgiumprice
  • Ireland
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Ethinylestradiolum + Drospirenonum
Manufacturer
Delfarma Sp. z o.o.
Country
Poland (PL)
ATC code
G03AA
ATC class
Progestogens and estrogens, fixed combinations
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991416881

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ethinylestradiolum + drospirenonum in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ethinylestradiolum + drospirenonum products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Aliane, Danselle 21
  • Belgium · Annaïs 20, Annaïs 30 Ceres Pharma
  • Bulgaria · Жанги, Крипинео
  • Cyprus · Yasmin, Yasminelle
  • Czechia · Abella, Cris
  • Germany · Aida, Drospifem 20
  • Denmark · Asubtela, Etindros 21
  • Estonia · Jangee, Madeleine
  • Spain · Aidra, Aidraelle
  • Finland · Diza, Midiana
  • France · Drospibel, Drospirenone/Ethinylestradiol
  • United Kingdom (Northern Ireland) · Dretine, Ellanite
  • Greece · Estrofix, Yasmin
  • Croatia · Crypineo, Rosanne
  • Hungary · Altforalle, Aranka
  • Ireland · Dretine, Dretinelle
  • Iceland · Asubtela, Yasmin
  • Italy · Calindir, Cris
  • Lithuania · Edrocont, Etindros
  • Luxembourg · Annaïs 20 Ceres Pharma, Annaïs 30 Ceres Pharma
  • Latvia · Etindros, Midiana
  • Malta · Edrocont, Freedonel
  • Netherlands · Baradly, Belanette
  • Norway · Calima, Diza
  • Portugal · Aranka, Arankelle
  • Romania · Yasmin
  • Sweden · Diza, Maitalon
  • Slovenia · Crypineo, Daylla
  • Slovakia · Daylla, Emie

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/842f972a-80f5-4bc6-8907-eb5cf439c523
GET /v1/drugs/842f972a-80f5-4bc6-8907-eb5cf439c523?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "0,03 mg + 3 mg",
  "packaging": "05909991416881 ¦ Rp ¦ 134369\n21 tabl.",
  "substance": "Ethinylestradiolum 0.03 mg + Drospirenonum 3 mg",
  "common_name": "Ethinylestradiolum + Drospirenonum",
  "pl_product_id": "100426730",
  "pozwolenie_nr": "385/19",
  "auth_procedure": "IR",
  "authorisation_validity": "2024-10-18"
}
API referenceMCP serverPlans

See everything about ethinylestradiolum + drospirenonum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console